Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat

Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression

(2018) Lindsay P. Cameron et al.   ACS Chemical Neuroscience

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study

(2018) Carla M. Canuso et al.   AMERICAN JOURNAL OF PSYCHIATRY

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression

(2018) Ella J. Daly et al.   JAMA Psychiatry

Confusing preclinical (predictive) drug screens with animal ‘models’ of psychiatric disorders, or ‘disorder-like’ behaviour, is undermining confidence in behavioural neuroscience

(2017) SC Stanford   JOURNAL OF PSYCHOPHARMACOLOGY

Sex differences and serotonergic mechanisms in the behavioural effects of psilocin

(2016) Filip Tylš et al.   BEHAVIOURAL PHARMACOLOGY

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

(2016) Roland R Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

(2016) Stephen Ross et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression

(2016) Kristian Gaarn du Jardin et al.   PSYCHOPHARMACOLOGY

Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat

(2015) Aline Pic-Taylor et al.   BEHAVIOURAL PROCESSES

Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats

(2015) Yuichi Sakashita et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

(2015) Michael P Bogenschutz et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Immobility in the forced swim test is adaptive and does not reflect depression

(2015) Marc L. Molendijk et al.   PSYCHONEUROENDOCRINOLOGY

Nitric oxide involvement in the antidepressant-like effect of ketamine in the Flinders sensitive line rat model of depression

(2014) Nico Liebenberg et al.   ACTA NEUROPSYCHIATRICA

The Ups and Downs of Modelling Mood Disorders in Rodents

(2014) D. A. Slattery et al.   ILAR JOURNAL

Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling

(2014) Tobias Buchborn et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

(2014) Matthew W Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Ketamine administration in depressive disorders: a systematic review and meta-analysis

(2014) Guillaume Fond et al.   PSYCHOPHARMACOLOGY

The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the Rat

(2014) Lukas Rambousek et al.   Frontiers in Behavioral Neuroscience

Serotonergic hallucinogens as translational models relevant to schizophrenia

(2013) Adam L. Halberstadt et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010

(2013) Alize J. Ferrari et al.   PLOS MEDICINE

Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning

(2013) Briony J. Catlow et al.   EXPERIMENTAL BRAIN RESEARCH

Using the rat forced swim test to assess antidepressant-like activity in rodents

(2012) David A Slattery et al.   Nature Protocols

Cost of disorders of the brain in Europe 2010

(2011) Anders Gustavsson et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers

(2011) Boris B Quednow et al.   NEUROPSYCHOPHARMACOLOGY